---
$id: https://graph.org.ai/products/commodity/51321712
$type: Product
source: UNSPSC
code: "51321712"
title: "Atorvastatin sodium"
class: "51321700"
classTitle: "Antihyperlipidemic and hypocholesterolemic fatty acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atorvastatin sodium

**UNSPSC Code**: 51321712
**Class**: [Antihyperlipidemic and hypocholesterolemic fatty acids](Antihyperlipidemic and hypocholesterolemic fatty acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hmg-coa reductase inhibitor with the molecular formula C33H34FN2O5.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DN43058TIV. European Medicines Agency schedules atorvastatin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35008. Most nations, for tariff and trade purposes, schedule atorvastatin sodium under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN SODIUM remains US FDA's Preferred Term for this commodity. Atorvastatin sodium bears US NLM identifiers UMLS ID C2698196 and NCI Concept Code C78676. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.[NA+].

